Involvement of HLA Antigens, Interleukin 2 Receptor and B-Cell Growth Factor in Interferon Action in Hairy Cell Leukemia

References

• Baldini L., Cortelezzi A., Polli N., Neri L., Nobili L., Maiolo A. T., Lambertenghi-Deliliers G., Polli E. E. Human recombinant interferon alpha-2C enhances the expression of class II HLA antigens on hairy cells. Blood 1986; 67: 458–464
   PubMed Web of Science ®Google Scholar
• Bergsagel D. E., Haas R. H., Messner H. A. Interferon in the treatment of chronic granulocytic leukemia. Interferons in Cancer Treatment, HKB Silver. MES Medical Education Services, Toronto, Canada 1986.; 59–66
   Google Scholar
• Boyd A. W., Fisher D. C., Fox D. A., Schlossman S. F., Nadler L. M. Structural and functional characterization of IL-2 receptors on activated human B cells. J. Immunol 1985; 134: 2387–2392
   PubMed Web of Science ®Google Scholar
• Chilosi M., Pizzolo G., Semenzata G., Cetto G. L. Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukemia. Intnl. J. Biol. Marker 1986; 1: 101–104
   PubMedGoogle Scholar
• Chilosi M., Semenzata G., Cetto G., Ambrosetti A., Fiore-Donati L., Perona G., Berton G., Lestani M., Scarpa A., Agostini C., Trentin L., Zambello R., Masciarelli M., Dazzi F., Vinante F., Caligaris-Cappio F., Pizzolo G. Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: Relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity. Blood 1987; 70: 1530–1535
   PubMed Web of Science ®Google Scholar
• Cossman J., Neckers L. M., Arnold A., Korsmeyer S. L. Induction of differentiation in a case of common acute lymphoblastic leukemia. New Engl. J. Med. 1982; 307: 1251–1255
   PubMed Web of Science ®Google Scholar
• Drouin J. Hairy cell leukemia: The role of therapy with interferons. Interferons in Cancer Treatment, HKB Silver. MES Medical Education Services, Toronto, Canada 1986.; 31–40
   Google Scholar
• Durno A. G., Ho D. D., Schooley R. T., Hirsch MS., MacKeen L. IP. S. H. Serum interleukin-2 (IL-2R) levels in human immunodeficiency virus (HIV) infection. Blood 1986; 68: 124a
   Google Scholar
• Ford R. J., Kwok D., Quesada J. R., Sahasrabuddhe C. G. Production of B cell growth factor(s) by neoplastic B cells from hairy cell leukemia patients. Blood 1986; 67: 573–577
   PubMed Web of Science ®Google Scholar
• Friedman R. M. Modulation of growth and differentiation by interferons. Interferons in Cancer Treatment, HKB Silver. MES Medical Education Services, Toronto, Canada 1986.; 11–16
   Google Scholar
• Gamliel H., Brownstein B. H., Gurfel D., Wu S. H., Rosner M. C., Golomb H. M. BCGF-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of HLA and Tac antigens. Cancer Res. 1989, submitted for publication
   Web of Science ®Google Scholar
• Gamliel H., Golomb H. M. Unique SEM features of hairy cells in hairy cell leukemia. Scanning Electron Microsc. 1986; IV: 1515–1521
   Google Scholar
• Gamliel H., Golomb H. M., Gurfel D., Hiraoka A., Rosner M. C., Polliack A. Hairy cell leukemia: Reevaluation of cell surface features under the SEM, using the “GTGO” air drying and critical point drying procedures. Scanning Electron Microsc. 1985; IV: 1665–1678
   Google Scholar
• Gamliel H., Gurfel D., Wu S. H., Golomb H. M. Interferon-induced surface alterations in hairy cells. A review. Scanning Microsc. Intnl. 1988; 2: 485–492
   PubMedGoogle Scholar
• Gamliel H., Hiraoka A., Golomb H. M. The effect of cultivation and interferon treatment on the surface morphology of hairy cell leukemia cells. Cancer Invest. 1987; 5: 389–399
   PubMed Web of Science ®Google Scholar
• Genot E., Billard C., Sigaux F., Mathiot C., Degos L., Falcoff E., Kolb J. P. Proliferative response of hairy cells to B cell growth factor (BCGF) in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma. Leukemia 1987; 1: 590–596
   PubMed Web of Science ®Google Scholar
• Golomb H. M. The treatment of hairy cell leukemia. Blood 1987; 69: 979–983
   PubMed Web of Science ®Google Scholar
• Golomb H. M., Fefer A., Golde D. W., Ozer H., Portlock C, Silber R., Rappaport H., Ratain M. J., Thompson J., Bonnem E. M. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia. Semin. Oncol. 1987; 14, (suppl. 2:), 13-17
   PubMed Web of Science ®Google Scholar
• Gordon J., Webb A. J., Walker L., Guy G. R., Rowe M. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor. Eur. J. Immunol. 1986; 16: 1627–1630
   PubMed Web of Science ®Google Scholar
• Huang A. T., Mold N. G. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry. Leukemia 1987; 1: 308–311
   PubMed Web of Science ®Google Scholar
• Korsmeyer S. J., Greene C. W., Cossman J., Hsu S. M., Jensen J. P., Neckers L. M., Marshall S. L., Bakhshi A., Depper J. M., Leonard W. J., Jaffe E. S., Waldmann T. A. Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia. Proc. Natl. Acad. Sci. USA 1983; 80: 4522–4526
   PubMed Web of Science ®Google Scholar
• MacKeen L., Brown M., Ip S. H., Kung P. C., Yasuda N., Harrington D., Hinuma Y., Weisenburger D., Lai P., Purtilo D. Serum interleukin-2 receptor as a marker for active T cell malignancies. Fed. Proc. 1986; 45: 454–459
   Google Scholar
• Matsuoka M., Hattori T., Kawano F., Ishii T., Uchiyama T., Takatsuki K. Expression of Tac antigen on human immature B-cell lineage leukemic cells. Leukemia Res. 1986; 10: 597–603
   PubMed Web of Science ®Google Scholar
• Mingari M. C., Gerosa F., Carra G., Accolla R. S., Moretta Z., Zubler R. H., Waldmann T. A., Moretta L. Human interleukin-2 promotes proliferation of activated cells via surface receptors similar to those of activated T cells. Nature 1984; 312: 641–643
   PubMed Web of Science ®Google Scholar
• Nelson D. L. Soluble interleukin-2 receptors: Analysis in normal individuals and in certain disease states. Fed. Proc. 1986; 45: 377–381
   Google Scholar
• Nelson D. L. The human interleukin-2 receptor: Normal and abnormal expression in T cells and HTLV-induced leukemias. Interleukins, W. C. Greene. Ann. Intern. Med. 1986.; 13–16
   Google Scholar
• Oshimi K., Oshimi Y., Akutsu M., Takei Y., Saito H., Okada M., Mizoguchi H. Cytotoxicity of interleukin-2 activated lymphocytes for leukemia and lymphoma cells. Blood 1986; 68: 938–948
   PubMed Web of Science ®Google Scholar
• Paganelli K. A., Evans S. S., Han T., Ozer H. B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro. Blood 1986; 67: 937–942
   PubMed Web of Science ®Google Scholar
• Pizzolo G., Chilosi M., Vinante F., Dazzi F., Lestani M., Perona G., Perini A., Todeschini G., Vincenzi C., Trentin L., Semenzata G. Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease. Br. J. Cancer 1987; 55: 427–433
   PubMed Web of Science ®Google Scholar
• Pui C. H., Ip S. H., Kung P., Dodge R., Berard C. W., Crist W. M., Murphy S. B. Serum interleukin-2 receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma. Blood 1987; 70: 624–628
   PubMed Web of Science ®Google Scholar
• Quesada J. R. Alpha interferons in hairy cell leukemia: a clinical model of biological therapy for cancer. Interferon 1987; 8: 111–134
   PubMedGoogle Scholar
• Quesada J. R., Hersh E. M., Manning J., Reuben J., Keating M., Schnipper E., Itri L., Gutterman J. U. Treatment of hairy cell leukemia with recombinant alpha-interferon. Blood 1986; 68: 493–497
   PubMed Web of Science ®Google Scholar
• Reuben J. M., Ip S., Quesada J. R. (1978) Effect of IFN-alpha therapy on cellular and plasma IL2R in hairy cell leukemia. Proc. 28th Annual Meeting of the American Society of Hematology, San Francisco, CA, 1986
   Google Scholar
• Revel M. The interferon system in man: Nature of the interferon molecules and mode of action. Antiviral Drugs and Interferon, Y. Becker. Martinus Nijhoff Publishing, Boston, MA 1984.; 357–433
   Google Scholar
• Rubin L. A., Kurman C. C., Fritz M. E., Biddson W. E., Boutin B., Yarchoan R., Nelson D. L. Soluble inter-leukin 2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. 1985; 135: 3172–3177
   PubMed Web of Science ®Google Scholar
• Silver H. K. B., Salinas F. A., Kong S. Role of interferons in immune regulation. Interferons in Cancer Treatment, HKB Silver. MES Medical Education Services, Toronto, Canada 1986.; 1–9
   Google Scholar
• Steis R. G., Marcon L., Clark J., Urba W., Longo D. L., Nelson D. L., Maluish A. E. Serum soluble IL-2 receptor as a tumor marker in patients with hairy cell leukemia. Blood 1988; 71: 1304–1309
   PubMed Web of Science ®Google Scholar
• Talpaz M., Kantarjian H. M., Kurzrock R., Gutterman J. U. Therapy of chronic myelogenous leukemia: chemotherapy and interferons. Semin. Hematol. 1988; 25: 62–73
   PubMed Web of Science ®Google Scholar
• Talpaz M., Kantarjian H. M., McCredie K. B., Keating M. J., Trujillo J., Gutterman J. U. Clinical investigation of human alpha interferon in chronic myelogeneous leukemia. Blood 1987; 69: 1280–1288
   PubMed Web of Science ®Google Scholar
• Waldmann T. A., Goldmann C. K., Robb R. J., Depper J. M., Leonard W. J., Sharrow S. O., Bongiovanni K. F., Kors-Meyer S. J., Green W. C. Expression of interleuktn-2 receptors on activated human B cells. J. Exp. Med. 1984; 160: 1450–1466
   PubMed Web of Science ®Google Scholar
• Wormann B., Anderson J. M., Ling Z. D., LeBien T. W. Structure/function analyses of IL-2 binding proteins on human B cell precursor acute lymphoblastic leukemias. Leukemia 1987; 1: 660–666
   PubMed Web of Science ®Google Scholar